Viewing StudyNCT00300781



Ignite Creation Date: 2024-05-05 @ 4:45 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00300781
Status: COMPLETED
Last Update Posted: 2018-08-14
First Post: 2006-03-07

Brief Title: Study Evaluating HKI-272 Neratinib In Subjects With Advanced Breast Cancer
Sponsor: Puma Biotechnology Inc
Organization: Puma Biotechnology Inc

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Breast Neoplasms
Keywords:
Name View
PB-272 View
phase 2 View
HER2 breast cancer View
monotherapy neratinib View
HKI-272 View
Neratinib View
Nerlynx View